Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, particularly during the initial weeks of treatment or following dose escalation
"A lot of clinicians and patients don't seem to recognize that GLP-1s don't work in everybody," G
The researchers noted that while drug-induced hypersensitivity reactions, including generalized pruritus and rash, have been documented, this presentation represented a delayed hypersensitivity reaction "characterized by well-defined, recurrent patches at discrete sites, driven by localized immune responses involving drug-specific cytotoxic T cells retained in the skin." Following discontinuation of semaglutide, the patient showed complete resolution of active lesions at 1-month follow-up, with residual postinflammatory hyperpigmentation
During the consultation, we will review the patients medical history, including any underlying medical conditions, medications, and lifestyle factors, to determine whether GLP-1 is a suitable treatment option We will explain how the medication works, its potential benefits and risks, and any lifestyle changes that will be necessary to optimize the treatment outcomes
Using a semaglutide vial beyond its assigned expiration date increases the risk of degraded potency, meaning lower doses than intended, and potential bacterial contamination if storage conditions were compromised
Key barriers include: High costs and insurer risk: Annual prices exceed $5,000 per patient (e.g., Wegovy at ~$450/month), straining small group plans where premiums could rise 10-20% with broad adoption
